Comment on «Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis» / Réplica a: «El análisis de supervivencia no es un buen método para evaluar la seguridad o la efectividad de los tratamientos sistémicos en psoriasis»
Actas dermo-sifiliogr. (Ed. impr.)
; 108(7): 695-696, sept. 2017.
Article
in English
| IBECS
| ID: ibc-166937
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
No disponible
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Psoriasis
/
Pharmaceutical Preparations
/
Drug Monitoring
Limits:
Humans
Language:
English
Journal:
Actas dermo-sifiliogr. (Ed. impr.)
Year:
2017
Document type:
Article
Institution/Affiliation country:
Radboud Institute of Health Sciences/The Netherlands
/
Radboud University Medical Center/The Netherlands